免疫接种是预防和控制传染病最成功的方法,帮助拯救了全球数百万人的生命。人乳头瘤病毒(HPV)感染与多种良性病症和癌症相关的发现推动了预防性HPV疫苗的开发。目前,药品市场上有四种HPV疫苗:Cervarix,Gardasil,Gardasil-9和最近开发的Cecolin。多项研究证明了HPV疫苗在预防HPV相关疾病方面的安全性和有效性。自2006年第一个HPV疫苗被批准以来,超过100个世界卫生组织成员国报告实施了HPV免疫接种.然而,HPV疫苗接种恐惧,担心它的安全,和相关的不良结局对世界各地的HPV疫苗实施活动有重大影响.许多发达国家已经成功实施了HPV免疫,并在预防HPV相关疾病方面取得了巨大的进展。然而,世界上仍然有许多国家没有创造,或尚未实施,HPV疫苗接种运动,或由于与建立成功的HPV疫苗接种计划相关的实现计划不足而失败。缺乏适当的HPV宣传活动,负面媒体反射,许多神话和虚假信息导致许多州的HPV疫苗排斥。因此,针对HPV疫苗接种安全性的特定环境健康教育干预,有效性,对于有效预防HPV相关疾病,提高疫苗接受度和获益是重要的。
Immunization is the most successful method in preventing and controlling infectious diseases, which has helped saving millions of lives worldwide. The discovery of the human papillomavirus (HPV) infection being associated with a variety of benign conditions and cancers has driven the development of prophylactic HPV vaccines. Currently, four HPV vaccines are available on the pharmaceutical market:
Cervarix, Gardasil, Gardasil-9, and the recently developed Cecolin. Multiple studies have proven the HPV vaccines\' safety and efficacy in preventing HPV-related diseases. Since 2006, when the first HPV vaccine was approved, more than 100 World Health Organization member countries reported the implementation of HPV immunization. However, HPV vaccination dread, concerns about its safety, and associated adverse outcomes have a significant impact on the HPV vaccine implementation campaigns all over the world. Many developed countries have successfully implemented HPV immunization and achieved tremendous progress in preventing HPV-related conditions. However, there are still many countries worldwide which have not created, or have not yet implemented, HPV vaccination campaigns, or have failed due to deficient realization plans associated with establishing successful HPV vaccination programs. Lack of proper HPV information campaigns, negative media reflection, and numerous myths and fake information have led to HPV vaccine rejection in many states. Thus, context-specific health educational interventions on HPV vaccination safety, effectiveness, and benefits are important to increase the vaccines\' acceptance for efficacious prevention of HPV-associated conditions.